EMBO Molecular Medicine · 2019 · 17 citations · 41 references
Life SciencesCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionAutocrine SignalingBone Morphogenetic Protein SignalingCell Signaling NetworksActivin RegulationAutocrine Growth SignalingAutocrine Signaling LoopsMedulloblastoma PathologyOncogenic TransformationTransforming Growth Factor Beta Receptor SignalingTransforming Growth Factor Beta ReceptorsTransforming Growth Factor-beta Signaling
Medulloblastoma (MB) is a pediatric tumor of the cerebellum divided into four groups. Group 3 is of bad prognosis and remains poorly characterized. While the current treatment involving surgery, radiotherapy, and chemotherapy often fails, no alternative therapy is yet available. Few recurrent genomic alterations that can be therapeutically targeted have been identified. Amplifications of receptors of the TGFβ/Activin pathway occur at very low frequency in Group 3 MB. However, neither their functional relevance nor activation of the downstream signaling pathway has been studied. We showed that this pathway is activated in Group 3 MB with some samples showing a very strong activation. Beside genetic alterations, we demonstrated that an ActivinB autocrine stimulation is responsible for pathway activation in a subset of Group 3 MB characterized by high PMEPA1 levels. Importantly, Galunisertib, a kinase inhibitor of the cognate receptors currently tested in clinical trials for Glioblastoma patients, showed efficacy on orthotopically grafted MB-PDX. Our data demonstrate that the TGFβ/Activin pathway is active in a subset of Group 3 MB and can be therapeutically targeted.
41
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor, Paul A. Northcott, Andrey Korshunov et al. · Acta Neuropathologica · 2011 · 2K citations · Full text
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek et al. · Cancer Cell · 2017 · 1.3K citations · Full text
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott, Ivo Buchhalter, A. Sorana Morrissy et al. · Nature · 2017 · 1.2K citations · Full text
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott, David Shih, John Peacock et al. · Nature · 2012 · 921 citations · Full text